Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study.

Yu-Wei Chang Hsiao-Li Kuo Tzu-Chien Chen Jessica Chen Ling Lim Kung-Liahng Wang Jen-Ruei Chen

Published in: Journal of gynecologic oncology (2024)

For patients with stage I, low-grade EEC, abnormal p53 expression may be used as an indicator of poor prognosis. Therefore, we suggest considering aggressive adjuvant therapies for these patients.

Keyphrases

poor prognosis
low grade
long non coding rna
end stage renal disease
high grade
newly diagnosed
ejection fraction
chronic kidney disease
early stage
peritoneal dialysis
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
patient reported
glycemic control